• Mashup Score: 0

    “The rates of complications for TAVR—especially complications related to bleeding—remain high,” lead author Vincent Nijenhuis, MD, a cardiologist at St. Antonius Hospital in the Netherlands, said in a statement. “This study helps physicians to better understand the risks of adding antiplatelet therapy to oral anticoagulants—namely, that doing so…

    Tweet Tweets with this article
    • Oral anticoagulation medication can help minimize bleeding complications among #AFib patients undergoing #TAVR, according to new research presented at #ACC20/#WCCardio. @CardioBusiness: https://t.co/JjHIygIsa7

  • Mashup Score: 1

    In patients who underwent surgical bioprosthetic valve implantation or repair, early postoperative anticoagulation with edoxaban was noninferior to warfarin for preventing thromboembolism and major bleeding during the first 3 months after the procedure, according to results of the ENAVLE trial presented at the virtual American College of Cardiology Scientific Session. “Our findings suggest

    Tweet Tweets with this article
    • Researchers at #ACC20/#WCCardio said edoxaban is noninferior to warfarin for preventing thromboembolism and major bleeding for first 3 mo. after surgical bioprosthetic valve implantation or repair. @CardiologyToday: https://t.co/sUMbUy5rfd